Canadian Sec - Delayed Quote CAD
Pharmala Biotech Holdings Inc. (MDMA.CN)
At close: October 18 at 3:38 PM EDT
Breakdown
8/31/2023
8/31/2022
8/31/2021
Total Assets
2,412.5380
2,330.0920
2,793.8400
Total Liabilities Net Minority Interest
1,029.0220
423.7830
138.4790
Total Equity Gross Minority Interest
1,383.5160
1,906.3090
2,655.3610
Total Capitalization
1,383.5160
1,906.3090
2,655.3610
Common Stock Equity
1,383.5160
1,906.3090
2,655.3610
Net Tangible Assets
-312.9700
665.4900
2,395.8430
Working Capital
-315.0720
661.6910
2,393.4790
Invested Capital
1,383.5160
1,906.3090
2,655.3610
Tangible Book Value
-312.9700
665.4900
2,395.8430
Total Debt
253.5370
--
--
Net Debt
58.4950
--
--
Share Issued
86,082.5520
82,998.6000
82,998.6000
Ordinary Shares Number
86,082.5520
82,998.6000
82,998.6000
8/31/2021 - 1/11/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHRM.CN PharmaTher Holdings Ltd.
0.2900
+23.40%
CYBN.NE Cybin Inc.
15.70
+9.64%
DRUG.CN Bright Minds Biosciences Inc.
102.72
+242.40%
MSCL.TO Satellos Bioscience Inc.
0.8000
+17.65%
PHRRF PharmaTher Holdings Ltd.
0.2080
+4.00%
HEM.V Hemostemix Inc.
0.0900
+12.50%
BIOV.CN BioVaxys Technology Corp.
0.0500
0.00%
XRTX.V XORTX Therapeutics Inc.
2.6900
+0.75%
CYBN Cybin Inc.
11.41
+9.19%
ARCH.V Arch Biopartners Inc.
2.1400
+7.00%